Integrin Receptor Antagonists

Integrin Receptor Antagonist

Colitis, Ulcerative

Crohn Disease

Enteritis

<section class="Section" data-sectioncode="34089-3"><a name="S11"></a><a name="section-9"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Vedolizumab, an integrin receptor antagonist, is a humanized IgG<span class="Sub">1 </span>monoclonal antibody produced in Chinese hamster ovary cells that binds to the human α4β7 integrin. ENTYVIO has an approximate molecular weight of 147 kilodaltons.</p><div class="Section" data-sectioncode="42229-5"><a name="section-9.1"></a><p></p><p class="First"><span class="Italics Underline">Intravenous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) for injection is supplied as a sterile, white to off-white, preservative-free, lyophilized cake for intravenous infusion. After reconstitution with 4.8 mL Sterile Water for Injection, USP, 0.9% Sodium Chloride Injection, USP, or Lactated Ringer's Injection, USP, the resulting concentration is 60 mg/mL with a deliverable volume of 5 mL (300 mg) and the resulting pH is approximately 6.3.</p><p>Each single-dose vial contains 300 mg vedolizumab, arginine hydrochloride (131.7 mg), histidine (23 mg), histidine monohydrochloride (21.4 mg), polysorbate 80 (3 mg), and sucrose (500 mg).</p></div><div class="Section" data-sectioncode="42229-5"><a name="section-9.2"></a><p></p><p class="First"><span class="Italics Underline">Subcutaneous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) injection is supplied as a sterile, clear to moderately opalescent, colorless to slightly yellow, preservative-free solution for subcutaneous administration.</p><p>Each single-dose prefilled syringe or single-dose prefilled pen (ENTYVIO PEN) contains 108 mg vedolizumab, arginine hydrochloride (17.77 mg), citric acid monohydrate (0.18 mg), histidine (3.86 mg), histidine monohydrochloride (1.86 mg), polysorbate 80 (1.35 mg), sodium citrate dihydrate (4.71 mg) and Sterile Water for Injection, USP, at a pH of 6.5.</p></div></section>

Entyvio

vedolizumab

vedolizumab 300 MG Injection

vedolizumab 300 MG Injection [Entyvio]

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe [Entyvio]

0.68 ML vedolizumab 159 MG/ML Auto-Injector

0.68 ML vedolizumab 159 MG/ML Auto-Injector [Entyvio]

Axium Healthcare de Puerto Rico

Abraxane

Actemra

Afinitor

Avastin

Benlysta

Besponsa

Blincyto

Bosulif

Braftovi

Cosentyx

Cotellic

Darzalex

Daurismo

Doxil

Enbrel

Empliciti

Erleada

Esbriet

Erivedge

Farydak

Fasenra

Folotyn

Gavreto

Halaven

Herceptin

Ibrance

Idhifa

Inlyta

Inrebic

Ixempa

Istodax

Kadcyla

Keytruda

Kyprolis

Lorbrena

Mayzent

Mekinist

Mektovi

Mylotarg

Ninlaro

Ocevrus

Odomzo

Olumiant

Oncaspar

Opdivo

Onureg

Pomalyst

Piqray

Reblozyl

Revlimid

Rituxan

Rozyltrek

Saphnelo

Stelara

Talzenna

Temodar

Thalomid

Tykerb

Vidaza

Voxzogo

Xolair

Zeposia

Entyvio | Axium Healthcare de Puerto Rico | limited distribution

Does Entyvio have a limited distribution partnership with Axium Healthcare de Puerto Rico?

Does Axium Healthcare de Puerto Rico work closely with Entyvio and Takeda Pharmaceuticals America, Inc.?

Does Axium Healthcare de Puerto Rico offer services for Entyvio patients?

What conditions does Axium Healthcare de Puerto Rico support?

How does Axium Healthcare de Puerto Rico help with insurance?